Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,734,872
+$1,023,475 QoQ
Shares Held
81,643
+1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#729
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Siemens Fonds Invest GmbH holds $98,160,775 across 10 Drug Manufacturers - General names. JNJ ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,769 | $24,910,963 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
81,643 | $20,734,872 | |
| 3 | ABBV |
AbbVie Inc.
|
57,804 | $14,545,798 | |
| 4 | AMGN |
Amgen Inc
|
28,142 | $10,190,781 | |
| 5 | MRK |
Merck & Co., Inc.
|
75,099 | $9,650,221 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
59,147 | $7,472,631 | |
| 7 | PFE |
Pfizer Inc
|
226,573 | $5,455,877 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
76,062 | $4,382,692 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,734,872 | 81,643 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,711,397 | 80,639 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,055,577 | 82,414 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,125,606 | 86,968 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,161,551 | 86,164 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,546,142 | 81,682 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,722,318 | 81,056 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $12,664,016 | 78,144 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,474,583 | 78,507 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,374,254 | 78,224 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,693,588 | 80,985 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,174,977 | 78,170 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,345,050 | 80,625 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,541,670 | 80,914 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,908,553 | 84,396 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,542,470 | 89,021 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,022,230 | 90,261 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $16,110,915 | 90,904 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $15,578,660 | 91,066 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,792,592 | 91,595 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,366,151 | 87,205 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $25,226,903 | 153,495 | Shares | Sole | 2021-07-14 | |
| 2020-12-31 | $23,567,655 | 149,750 | Shares | Sole | 2021-07-14 | |
| No filing history on record for this holder in this stock. | ||||||